The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4 by Jin Zhou (90734)

DLS mGluR1/5 signaling activation in instrumental conditioning and differential behavioral sensitivity to A–O changes with training duration. by Vincent Paget-Blanc (21807763)

Video_5_Why Does Child Mortality Decrease With Age? Modeling the Age-Associated Decrease in Mortality Rate Using WHO Metadata From 25 Countries.MP4 by Josef Dolejs (5534258)

Macrophages play a role in esAEV-induced proliferation. by Safia A. Essien (20108379)

Argon-mediated decrease of apoptosis is attenuated following ERK1/2 and TLR inhibition. by Felix Ulbrich (678720)

Decreased expression of xenoantigen Neu5Gc in hiPSCs adapted under defined culture conditions. by Yohei Hayashi (236734)

5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection. by Li Gao (131516)

DPI, NAC and resveratrol decrease lipolysis. by Sarah A. Krawczyk (172699)

<i>TUG1</i> influences VEGFA-stimulated sprouting. by Anna Theresa Gimbel (13883632)

NeuN expression and neuronal apoptosis in Sham and severely injured groups. by Xinhui Zhang (1624039)

(A) Kaplan-Meier survival curves showing 28-day survival rates between the two groups;(B) ROC analysis of death risk factors in SFTS patients with HLH. by Bo Zhang (6559)

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

“…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”

Changes in the normalized volume <i>v</i> = V/V₀ of HEK293 cells in response to sequential application of sucrose and <i>myo</i>-inositol solutions of the same osmolalit... by Joseph Andronic (700242)

“…<p>The cells were bathed initially (<i>time</i> < ∼30 s) in isotonic growth medium (300 mOsm) and then exposed to a 100-mOsm sucrose solution. The strongly hypotonic sucrose solution (<i>filled symbols</i>) caused fast cell swelling to a transient maximum volume <i>v</i>_max of ∼1.6 within the first 2–3 min. …”

Sensitivity of U251 stable clones to GCV. by Elizabeth Wei-Chia Luo (11250668)

“…<p>U251, U251-pCMV-HSVtk, and U251-pGFAP-HSVtk cells were treated with 0, 1, 5, or10 μg/ml of GCV for 5 days. (A–D) Live-cell phase images of U251 parent cells displayed no cytotoxicity up to 10 μg/ml of GCV. …”

Patterns of nestin, GFAP, and βIII-tubulin expression in U251-pCMV-HSVtk cells. by Elizabeth Wei-Chia Luo (11250668)

“…(D–F) Filamentous expression of nestin was observed at day 5, day 7, and after recovery. U251-pCMV-HSVtk cells expressed GFAP strongly at day 0 (G), and then gradually decreased expression during 7 days of GCV treatment (H–K). …”

Fermentation must reducing sugar (A, strain A; B, strain B; C, strain F) and fermentation ethanol concentration (D, strain A; E, strain B; F, strain F) for <i>S. cerevisiae</i> str... by Xiang-yu Sun (748032)

Intracellular ROS decrease mediated by TAT-fused protein delivery. by Cecilia L. Balaban (4424212)

Fig 5 - by Liying Zhang (102453)

Inhibition of F/P tyrosine kinase by imatinib in CEL patients decreased phosphorylation of JAK2, Stat3 and Stat5 in a time-dependent manner. by Bin Li (39349)